ATE439123T1 - Verwendung von emulsionen zur intra- und periocularen injection - Google Patents

Verwendung von emulsionen zur intra- und periocularen injection

Info

Publication number
ATE439123T1
ATE439123T1 AT04291684T AT04291684T ATE439123T1 AT E439123 T1 ATE439123 T1 AT E439123T1 AT 04291684 T AT04291684 T AT 04291684T AT 04291684 T AT04291684 T AT 04291684T AT E439123 T1 ATE439123 T1 AT E439123T1
Authority
AT
Austria
Prior art keywords
intra
emulsions
periocular injection
periocular
injection
Prior art date
Application number
AT04291684T
Other languages
English (en)
Inventor
Laura Rabinovich-Guilatt
Kozak Yvonne De
Catherine Dubernet
Gregory Lambert
Simon Benita
Patrick Couvreur
Francine Behar-Cohen
Original Assignee
Novagali Pharma Sa
Centre Nat Rech Scient
Inst Nat Sante Rech Med
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novagali Pharma Sa, Centre Nat Rech Scient, Inst Nat Sante Rech Med, Yissum Res Dev Co filed Critical Novagali Pharma Sa
Application granted granted Critical
Publication of ATE439123T1 publication Critical patent/ATE439123T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
AT04291684T 2004-07-02 2004-07-02 Verwendung von emulsionen zur intra- und periocularen injection ATE439123T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04291684A EP1611879B1 (de) 2004-07-02 2004-07-02 Verwendung von Emulsionen zur intra- und periocularen Injection

Publications (1)

Publication Number Publication Date
ATE439123T1 true ATE439123T1 (de) 2009-08-15

Family

ID=34931219

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04291684T ATE439123T1 (de) 2004-07-02 2004-07-02 Verwendung von emulsionen zur intra- und periocularen injection

Country Status (4)

Country Link
US (1) US20060002963A1 (de)
EP (1) EP1611879B1 (de)
AT (1) ATE439123T1 (de)
DE (1) DE602004022523D1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2578176C (en) 2004-11-09 2013-09-24 Novagali Pharma Sa Ophthalmic emulsions containing an immunosuppressive agent
EP1655021B1 (de) 2004-11-09 2008-10-29 Novagali Pharma SA Öl-in-Wasser-Emulsion mit niedriger Konzentration des kationischen Mittels und positivem Zetapotential
EA035619B1 (ru) 2005-06-01 2020-07-16 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Композиции для использования в способе лечения митохондриальных нарушений
US8067433B2 (en) * 2005-11-09 2011-11-29 Zalicus Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
EP1986636B1 (de) 2006-02-22 2013-04-24 Edison Pharmaceuticals, Inc. Phenol- und 1,4-benzochinon-derivate zur verwendung in der behandlung von erkrankungen der mitochondrien
US7767217B2 (en) * 2006-03-14 2010-08-03 Foresight Biotherapeutics Ophthalmic compositions comprising povidone-iodine
CN100435843C (zh) * 2006-04-21 2008-11-26 北京国丹药物技术开发有限公司 一种胸腺五肽与干扰素的组合物
EP1864668B1 (de) * 2006-06-01 2012-11-21 Novagali Pharma S.A. Verwendung von Arzneimittelpräkursor für okuläre intravitrealen Verabreichung
WO2008035246A2 (en) 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
CN101130058B (zh) * 2006-08-23 2011-10-05 华北制药集团新药研究开发有限责任公司 一种环孢菌素a眼用乳剂及其制备方法
US9125807B2 (en) 2007-07-09 2015-09-08 Incept Llc Adhesive hydrogels for ophthalmic drug delivery
CA2723358A1 (en) * 2008-05-05 2009-11-12 Allison B. Reiss Method for improving cardiovascular risk profile of cox inhibitors
WO2009149418A2 (en) 2008-06-06 2009-12-10 Asuragen, Inc. Novel compositions for the in vivo delivery of rnai agents
EP2344142B1 (de) 2008-09-10 2024-06-26 PTC Therapeutics, Inc. Behandlung von pervasiven entwicklungsstörungen mit redox-aktiven therapeutika
JP5890182B2 (ja) 2009-02-12 2016-03-22 インセプト エルエルシー ヒドロゲルプラグによる薬物送達
CA2777479C (en) 2009-04-28 2017-10-17 Ptc Therapeutics, Inc. Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
EP2493471B1 (de) 2009-10-26 2019-11-27 Thomas Julius Borody Neue enterale kombinationstherapie
TW201138782A (en) * 2010-04-26 2011-11-16 Besins Healthcare Lu Sarl Low-oil pharmaceutical emulsion compositions comprising progestogen
US8961501B2 (en) 2010-09-17 2015-02-24 Incept, Llc Method for applying flowable hydrogels to a cornea
WO2012138003A1 (ko) * 2011-04-08 2012-10-11 경북대학교 산학협력단 탈황산화된 헤파린-담즙산 유도체의 염증성 질환의 예방 및 치료 용도
US10226417B2 (en) 2011-09-16 2019-03-12 Peter Jarrett Drug delivery systems and applications
US9205150B2 (en) 2011-12-05 2015-12-08 Incept, Llc Medical organogel processes and compositions
DK2928921T3 (da) 2012-12-05 2021-04-19 Novartis Ag Sammensætninger og fremgangsmåder til antistoffer målrettet epo
RU2539161C2 (ru) * 2012-12-17 2015-01-10 Танзиля Сыонгалиевна Корнилова Способ лечения герпесвирусного поражения внутренних оболочек глаза
CA2991921C (en) 2014-07-30 2023-08-08 Massachusetts Eye And Ear Infirmary Methotrexate for proliferative vitreoretinopathy
ES2913530T3 (es) 2015-08-12 2022-06-02 Novartis Ag Métodos para tratar trastornos oftálmicos
EP3389646A1 (de) 2015-12-17 2018-10-24 BioElectron Technology Corporation Flouralkyl, flouralkoxy, phenoxy, heteroaryloxy, alkoxy und amin-1,4-benzochinon-derivate zur behandlung von oxidativen stresserkrankungen
KR102472774B1 (ko) 2016-08-19 2022-11-30 오라시스 파마슈티칼스 엘티디. 안과용 약학 조성물 및 이와 관련된 용도
EP3484463B1 (de) 2016-08-19 2020-02-12 The United States of America, as Represented by The Secretary, Department of Health and Human Services Office of Technology Transfer Selektive östrogenrezeptormodulatoren (serm) zur verleihung von schutz gegen photorezeptordegeneration
FR3057774B1 (fr) * 2016-10-21 2025-11-07 Museum Nat Dhistoire Naturelle Derives de la purine pour leur utilisation dans le traitement ou la prevention de maladies dues a une mutation non-sens
CN106963725A (zh) * 2017-04-19 2017-07-21 赵艳霞 一种地塞米松纳米凝胶及其制备方法
CN113648421A (zh) * 2021-08-19 2021-11-16 中山大学中山眼科中心 磺酰脲类药物在制备治疗葡萄膜炎的药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5098443A (en) * 1989-03-23 1992-03-24 University Of Miami Method of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents
US5294604A (en) * 1989-12-20 1994-03-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating ocular diseases by periocular administration of cyclosporine A or G
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
IL98747A0 (en) * 1991-07-05 1992-07-15 Yissum Res Dev Co Ophthalmic compositions
IL101241A (en) * 1992-03-16 1997-11-20 Yissum Res Dev Co Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
US5496811A (en) * 1992-08-28 1996-03-05 Pharmos Corp. Submicron emulsions as ocular drug delivery vehicles
WO1995003009A1 (en) * 1993-07-22 1995-02-02 Oculex Pharmaceuticals, Inc. Method of treatment of macular degeneration
WO1995003807A1 (en) * 1993-07-27 1995-02-09 The University Of Sydney Treatment of age-related macular degeneration
WO1999016471A1 (en) * 1997-10-01 1999-04-08 Wakamoto Pharmaceutical Co., Ltd. O/w emulsion compositions
DE10036871A1 (de) * 2000-07-28 2002-02-14 Pharmasol Gmbh Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
EP1441696B1 (de) * 2001-11-01 2010-05-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Verfahren und zusammensetzung zur behandlung von trockenen augen

Also Published As

Publication number Publication date
EP1611879A1 (de) 2006-01-04
DE602004022523D1 (de) 2009-09-24
US20060002963A1 (en) 2006-01-05
EP1611879B1 (de) 2009-08-12

Similar Documents

Publication Publication Date Title
DE602004022523D1 (de) Verwendung von Emulsionen zur intra- und periocularen Injection
ATE498395T1 (de) Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung
DE602004027936D1 (de) Tocopherolmodifizierte therapeutische arzneimittelverbindung
ATE413162T1 (de) Pharmazeutische zusammensetzungen zur sicheren verabreichung von bei der behandlung von drogenabhängigkeit verwendeten arzneimitteln
EP2058010A4 (de) Pharmazeutische zusammensetzung
ATE513562T1 (de) Nicht-spezifische immunstimulierende mittel
CY1118179T1 (el) Φαρμακευτικη συνθεση
DK1587506T3 (da) Administration af capsaicinoider
EA200401252A1 (ru) Микрочастицы лекарственных веществ
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
BRPI0518460A2 (pt) mÉtodo para tratar emergÊncia alÉrgica em um paciente, dispositivo de distribuiÇço de droga contendo uma soluÇço de epinefrina, e, kit para tratar uma emergÊncia alÉrgia'
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
MXPA05006670A (es) Administracion de capsaicinoides.
WO2006008639A8 (en) Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody
CY1109070T1 (el) Διαδερμικη μορφη δοσολογιας περιλαμβανουσα ενα δραστικο παραγοντα και ενα αλας και μια μορφη ελευθερης βασεως ενος ανταγωνιστη
BRPI0519195A2 (pt) composiÇço de cuidado oral, e, mÉtodo para prevenir ou tratar cÁrie dental em um indivÍduo humano ou animal
WO2008117268A3 (en) A drug delivery device for providing local analgesia, local anesthesia or nerve blockade
ATE322265T1 (de) Pharmazeutische zusammensetzung zur behandlung von kolorektalem krebs welche thalidomid und irinotecan enthält
SE0301663D0 (sv) Analysmetod för infusionsläkemedel
ATE464878T1 (de) Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl
ATE434431T1 (de) Pharmazeutische formulierungen mit kurzketten- sphingolipiden und ihre verwendung
CR9200A (es) Uso de un agonista 5-ht6 para el tratamiento y la prevencion de trastornos neurodegenerativos
BRPI0508596A (pt) combinação compreendendo ligante alfa-2-delta
DK1617827T3 (da) Farmaceutisk sammensætning i form af en hydrogel til den transdermale administration af aktivstoffer
DE60135390D1 (de) Verwendung von nefiracetam zur behandlung von postischemischer neurodegeneration

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties